Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat

Background/Aims: We aimed to evaluate whether pancreatic kininogenase (PKase) can relieve renal fibrosis and investigate its mechanisms in diabetic nephropathy (DN) rats Methods: We established streptozotocin (STZ) induced-DN rats. After treatment with PKase for 4 weeks, urinary weight, urinary prot...

Full description

Bibliographic Details
Main Authors: Dan Zhu, Linlin Zhang, Lijuan Cheng, Liansheng Ren, Jie Tang, Dianjun Sun
Format: Article
Language:English
Published: Karger Publishers 2016-01-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:http://www.karger.com/Article/FullText/368542
_version_ 1818541560412766208
author Dan Zhu
Linlin Zhang
Lijuan Cheng
Liansheng Ren
Jie Tang
Dianjun Sun
author_facet Dan Zhu
Linlin Zhang
Lijuan Cheng
Liansheng Ren
Jie Tang
Dianjun Sun
author_sort Dan Zhu
collection DOAJ
description Background/Aims: We aimed to evaluate whether pancreatic kininogenase (PKase) can relieve renal fibrosis and investigate its mechanisms in diabetic nephropathy (DN) rats Methods: We established streptozotocin (STZ) induced-DN rats. After treatment with PKase for 4 weeks, urinary weight, urinary protein content and blood glucose concentration were detected, and then renal histopathological changes were examined using Hematoxylin and Eosin (H&E) and Masson's thrchrome staining. In addition, the expressions of miR-433, transforming growth factor-β1 (TGF-β1) and antizyme inhibitor 1 (Azin1) were detected by qRT-PCR and/or western blotting. Results: PKase reduced urinary weight, urinary protein contents and blood glucose concentrations. PKase treated DN rats exhibited less renal fibrosis than untreated DN rats (P P P Conclusions: PKase might not only inhibit the development of DN by reducing urinary weight, urinary protein content and blood glucose concentration in DN rats, but also relieve renal fibrosis in DN rats through inhibiting the expression of TGF-β1, and miR-433 and Azin1 might involve in this process.
first_indexed 2024-12-11T22:10:53Z
format Article
id doaj.art-2e6b58d36ad64c0d90dbb2ac39a22574
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-12-11T22:10:53Z
publishDate 2016-01-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-2e6b58d36ad64c0d90dbb2ac39a225742022-12-22T00:48:46ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432016-01-0141191710.1159/000368542368542Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy RatDan ZhuLinlin ZhangLijuan ChengLiansheng RenJie TangDianjun SunBackground/Aims: We aimed to evaluate whether pancreatic kininogenase (PKase) can relieve renal fibrosis and investigate its mechanisms in diabetic nephropathy (DN) rats Methods: We established streptozotocin (STZ) induced-DN rats. After treatment with PKase for 4 weeks, urinary weight, urinary protein content and blood glucose concentration were detected, and then renal histopathological changes were examined using Hematoxylin and Eosin (H&E) and Masson's thrchrome staining. In addition, the expressions of miR-433, transforming growth factor-β1 (TGF-β1) and antizyme inhibitor 1 (Azin1) were detected by qRT-PCR and/or western blotting. Results: PKase reduced urinary weight, urinary protein contents and blood glucose concentrations. PKase treated DN rats exhibited less renal fibrosis than untreated DN rats (P P P Conclusions: PKase might not only inhibit the development of DN by reducing urinary weight, urinary protein content and blood glucose concentration in DN rats, but also relieve renal fibrosis in DN rats through inhibiting the expression of TGF-β1, and miR-433 and Azin1 might involve in this process.http://www.karger.com/Article/FullText/368542Transforming growth factor-β1Pancreatic KininogenaseRenal fibrosisAntizyme inhibitor 1MiR-433
spellingShingle Dan Zhu
Linlin Zhang
Lijuan Cheng
Liansheng Ren
Jie Tang
Dianjun Sun
Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
Kidney & Blood Pressure Research
Transforming growth factor-β1
Pancreatic Kininogenase
Renal fibrosis
Antizyme inhibitor 1
MiR-433
title Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
title_full Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
title_fullStr Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
title_full_unstemmed Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
title_short Pancreatic Kininogenase Ameliorates Renal Fibrosis in Streptozotocin Induced-Diabetic Nephropathy Rat
title_sort pancreatic kininogenase ameliorates renal fibrosis in streptozotocin induced diabetic nephropathy rat
topic Transforming growth factor-β1
Pancreatic Kininogenase
Renal fibrosis
Antizyme inhibitor 1
MiR-433
url http://www.karger.com/Article/FullText/368542
work_keys_str_mv AT danzhu pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat
AT linlinzhang pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat
AT lijuancheng pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat
AT lianshengren pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat
AT jietang pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat
AT dianjunsun pancreatickininogenaseamelioratesrenalfibrosisinstreptozotocininduceddiabeticnephropathyrat